Chronic Drug-Induced Liver Injury: Updates and Future Challenges

Chronic drug-induced liver injury (DILI), defined as DILI with persistent liver injury more than one year after the first onset by the latest European guidelines, is a notable challenge globally with big issues of defining causality and establishing effective treatment. About 20% of patients with DI...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiaoling, Huang, Ang, Wang, Jia-Bo, Zou, Zhengsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982586/
https://www.ncbi.nlm.nih.gov/pubmed/33762948
http://dx.doi.org/10.3389/fphar.2021.627133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982586/
https://www.ncbi.nlm.nih.gov/pubmed/33762948
http://dx.doi.org/10.3389/fphar.2021.627133

Ejemplares similares